Palpitations in athletes

Sports Medicine

Volumn 38, Issue 8, 2008, Pages 687-702

  Lawless, Christine E ^a,c   Briner, William ^b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b ADVOCATE LUTHERAN GENERAL HOSPITAL   (United States)

^c Sports Cardiology Consultants LLC   (United States)

Author keywords

Palpitations; Sports

Indexed keywords

ATHLETE; CARDIOVASCULAR RISK; DIFFERENTIAL DIAGNOSIS; ELECTROCARDIOGRAM; ENDURANCE SPORT; HEART PALPITATION; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; MEDICAL RESEARCH; PROGNOSIS; REVIEW; SINUS TACHYCARDIA; SPORTS MEDICINE; TELEMETRY; TRAINING;

ADOLESCENT; ADULT; ARRHYTHMIAS, CARDIAC; CHILD; HUMANS; INCIDENCE; PROGNOSIS; RISK ASSESSMENT; SPORTS;

EID: 47349113889     PISSN: 01121642     EISSN: None     Source Type: Journal    
DOI: 10.2165/00007256-200838080-00006     Document Type: Review

References (49)

1. Glover DW, Maron BJ. Profile of preparticipation cardiovascular screening for high school athletes. JAMA 1998; 279: 1817-9
2. Pfister GC, Puffer JC, Maron BJ. Preparticipation cardiovascular screening for US collegiate student-athletes. JAMA 2000; 283: 1597-9
3. Pellicia A, Maron BJ. Preparticipation cardiovascular evaluation of the competitive athlete: perspectives from the 30-year Italian experience. Am J Cardiol 1995; 75: 827-9
4. Corrado D, Basso C, Schiavon M, et al. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 1998; 339: 364-9
5. Maron BJ, Zipes DP. 36th Bethesda Conference: eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol 2005; 45: 1-64
6. Estes NA, Link MS, Cannom D, et al. Report of the NASPE policy conference on arrhythmias and the athlete. J Cardiovasc Electrophysiol 2001; 12: 1208-19
7. Maron BJ, Araujo CG, Thompson PD, et al. Recommendations for preparticipation screening and the assessment of cardiovascular disease in masters athletes: an advisory for healthcare professionals from the working groups of the World Heart Federation, the International Federation of Sports Medicine, and the American Heart Association Committee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation 2001; 103: 327-34
8. Maron BJ, Chaitman BR, Ackerman MJ, et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 2004; 109 (22): 2807-16
9. Weber BE, Kapoor WN. Evaluation and outcomes of patients with palpitations. Am J Med 1996; 100: 138-48
10. Fuller CM, McNulty CM, Spring DA, et al. Prospective screening of 5615 high school athletes for risk of sudden cardiac death. Med Sci Sports Exer 1997; 29: 1131-8
11. Niwa K, Warita N, Sunami Y, et al. Prevalence of arrhythmias and conduction disturbances in large population-based samples of children. Cardiol Young 2004; 14: 68-74
12. Biffi A, Pelliccia A, Verdile L, et al. Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol 2002; 40: 446-52
13. Furlanello F, Bertoldi A, Dallago M, et al. Atrial fibrillation in elite athletes. J Cardiovasc Electrophysiol 1998; 9: S63-8
14. Karjalainen J, Kujala UM, Kaprio J, et al. Lone atrial fibrillation in vigorously exercising middle-aged men: case control study. BMJ 1998; 316: 1784-5
15. Talan DA, Bauernfeind RA, Ashley WW, et al. Twenty-four hour continuous ECG recordings in long-distance runners. Chest 1982; 82: 19-24
16. Maron BJ, Olivotto I, Spirito P, et al. Epidemiology of hypertrophic cardiomyopathy-related death. Circulation 2000; 102: 858-64
17. Smith DM, Kovan JR, Rich BSE, et al. Preparticipation physical evaluation. 2nd ed. Minneapolis (MN): McGraw-Hill, 1997: 1-46
18. Preparticipation physical evaluation. 3rd ed. Minneapolis (MN): McGraw-Hill/The Physician and Sports-Medicine, 2005
19. Foote CB, Michaud G. The athletes ECG: distinguishing normal from abnormal. In: Estes NA, Salem D, Wang PJ, editors. Sudden cardiac death in the athlete. Armonk (NY): Futura, 1998: 101-14
20. Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long Q-T syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001; 103: 89-95
21. Barsky AJ. Palpitations, cardiac awareness, and panic disorder. Am J Med 1992; 92: 31-4S
22. Barsky AJ, Cleary PD, Coeytaux RR, et al. Psychiatric disorders in medical outpatients complaining of palpitations. J Gen Int Med 1994; 9: 306-13
23. Witchel HJ, Hancox JC, Nutt D. Psychotrophic drugs, cardiac arrythmia, and sudden death. J Clin Psychopharmacol 2003; 23: 58-77
24. Knudsen MP. The natural history of palpitations in a family practice. J Fam Pract 1987; 24: 357-60
25. Biffi A, Maron BJ, Verdile L, et al. Impact of physical deconditioning on ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol 2004; 44: 1053-8
26. Kinlay S, Leitch JW, Neil A, et al. Cardiac event recorders yield more diagnoses and are more cost-effective than 48 hour Holter monitoring in patients with palpitations: a controlled clinical trial. Ann Intern Med 1996; 124: 16-20
27. Fogel RI, Evans JJ, Prystowsky EN. Utility and cost of event recorders in the diagnosis of palpitations, presyncope and syncope. Am J Cardiol 1997; 79: 207-8
28. Zimetbaum PJ, Josephson ME. The evolving role of ambulatory arrhythmia monitoring in general clinical practice. Ann Intern Med 1999; 130: 848-56
29. Krahn AD, Klein GJ, Yee R, et al., for the Reveal Investigators. Use of an extended monitoring strategy in patients with problematic syncope. Circulation 1999; 99: 406-10
30. Maron BJ, Barry J, Mitten MJ, et al. Competitive athletes with cardiovascular disease: the case of Nicholas Knapp. N Engl J Med 1998; 339 (22): 1632-5
31. Krahn AD, Yee R, Klein GJ, et al. Inappropriate sinus tachycardia: evaluation and therapy. J Cardiovasc Electrophysiol 1995; 6: 1124-8
32. Shen WK. How to manage patients with inappropriate sinus tachycardia. Heart Rhythm 2005; 2 (9): 1015-9
33. Samenuk D, Link MS, Hamoud MK, et al. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clinic Proc 2002; 77: 12-6
34. Estes NA, Kloner R, Olshansky B, et al. Task Force 9: drugs and performance-enhancing substances. J Am Coll Cardiol 2005; 45 (8): 1368-9
35. Furlanello F, Bentivegna S, Cappato R, et al. Arrhythmogenic effects of illicit drugs in athletes. Ital Heart J 2003; 4 (12): 829-37
36. McLeod KA. Dizziness and syncope in adolescence. Heart 2001; 86: 350-4
37. Stewert JM, Gewitz MH, Weldon A, et al. Orthostatic intolerance in adolescent chronic fatigue syndrome. Pediatrics 1999; 103: 116-21
38. Fischer B, Haissaguerre M, Garrigues S, et al. Radiofrequency catheter ablation of common atrial flutter in 80 patients. J Am Coll Cardiol 1995; 25: 1365-72
39. Hoogsteen J, Schep G, Van Hemel NM, et al. Paroxysmal atrial fibrillation in male endurance athletes: a 9-year follow up. Europace 2004; 6 (3): 222-8
40. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659-66
41. Haissaguerre M, Jais P, Shah DC, et al. Electrophysiological endpoint for catheter ablation of atrial fibrillation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 2000; 101: 1409-17
42. Naccarelli GV, Shih H, Jalal S. Catheter ablation for the treatment of paroxysmal supraventricular tachycardia. J Cardiovasc Electrophysiol 1995; 6: 951-61
43. Calkins H, Yong P, Miller JM, et al. Catheter ablation of accessory pathways, atrioventricular nodal reentry tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. Circulation 1999; 99: 262-70
44. Klein GJ, Bashore TM, Sellers TD, et al. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med 1979; 301: 1080-5
45. Nogami A. Idiopathic left ventricular tachycardia: assessment and treatment. Cardiac Electrophysiol Rev 2002; 6: 448-57
46. Cole CR, Marrouche NF, Natale A. Evaluation and management of ventricular outflow tract tachycardias. cardiac electrophysiology review 2002; 6: 442-7
47. Lerman BB, Stein KM, Markowitz SM, et al. Ventricular arrhythmias in normal hearts. Cardiol Clin 2000; 18 (2): 265-91
48. Ouyang F, Cappato R, Ernst S, et al. Electroanatomic substrate of idiopathic left ventricular tachycardia. Circulation 2002; 105: 462-9
49. Maruyama M, Tadera T, Miyamoto S, et al. Demonstration of the reentrant circuit of verapamil-sensitive idiopathic left ventricular tachycardia: direct evidence for macroreentry as the underlying mechanism. J Cardiovasc Electrophysiol 2001; 12: 968-72